Valuation: Inogen, Inc.

Market Cap 147M 126M 118M 108M 204M 14.02B 206M 1.39B 542M 7.07B 552M 540M 23.42B P/E 2026 *
-7.32x
P/E 2027 * -11.9x
Enterprise Value 147M 126M 118M 108M 204M 14.02B 206M 1.39B 542M 7.07B 552M 540M 23.42B EV / Sales 2026 *
0.41x
EV / Sales 2027 * 0.39x
Free-Float
87.11%
Yield 2026 *
-
Yield 2027 * -
1 day+0.73%
1 week-1.07%
Current month-14.11%
1 month-9.92%
3 months-13.44%
6 months-7.82%
Current year-17.56%
1 week 5.48
Extreme 5.48
5.71
1 month 5.48
Extreme 5.48
6.93
Current year 5.34
Extreme 5.3401
7.67
1 year 5.34
Extreme 5.3401
9.13
3 years 4.13
Extreme 4.13
13.33
5 years 4.13
Extreme 4.13
61.78
10 years 4.13
Extreme 4.13
287.79
Manager TitleAgeSince
Chief Executive Officer 55 09/11/2023
Director of Finance/CFO 48 05/04/2026
Chief Operating Officer 56 05/07/2026
Director TitleAgeSince
Director/Board Member 66 05/08/2014
Chairman 65 28/12/2021
Director/Board Member 59 21/03/2022
Date Insider Type Main position Quantity % Market Cap.
06/07/26 Free

Chief Operating Officer

-130,000 0.4802%
01/07/26 Sell

Head of Human Resources

-10,938 0.0404%
27/02/26 Free

Chief Executive Officer

284,687 1.0486%
Change 5-day change 1-year change 3-year change Capi.($)
+0.73%-1.07%-28.15%-7.51% 147M
-0.46%+3.06%-11.94%+11.44% 201B
-1.89%-1.03%-0.98%+10.89% 117B
+1.33%+3.77%+13.79%+82.78% 62.6B
-0.12%-1.77%+29.62%+56.62% 52.49B
-0.50%+4.98%-2.50%-32.22% 51.69B
-2.09%-0.49%+17.38%-11.51% 33.65B
+2.71%+4.45% - - 31.27B
-1.37%+0.55%+40.97%-11.49% 24.52B
-0.94%+4.05%-2.80%+19.77% 24.05B
Average -0.35%+1.14%+6.16%+13.20% 59.8B
Weighted average by Cap. -0.19%+1.53%+2.28%+17.40%

Financials

2026 *2027 *
Net sales 356M 305M 286M 261M 493M 33.99B 498M 3.38B 1.31B 17.15B 1.34B 1.31B 56.79B 373M 320M 300M 274M 517M 35.58B 522M 3.53B 1.38B 17.95B 1.4B 1.37B 59.44B
Net income -20.6M -17.65M -16.54M -15.11M -28.51M -1.96B -28.79M -195M -75.95M -991M -77.35M -75.66M -3.28B -13M -11.14M -10.44M -9.53M -17.99M -1.24B -18.17M -123M -47.93M -625M -48.81M -47.75M -2.07B
Net Debt - -
Logo Inogen, Inc.
Inogen, Inc. is a global medical technology company offering respiratory products for use in the homecare setting. The Company partners with patients, prescribers, home medical equipment providers, and distributors to make its respiratory therapy products available. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators (POCs), used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. It also distributes the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure (CPAP) masks in the United States. Its proprietary Inogen One and Inogen Rove POC systems concentrate the air around the patient to offer a source of supplemental oxygen 24 hours a day, seven days a week with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available.
Employees
753
Date Price Change Volume
25/08/26 US$5.540 +0.73% 166,314
24/08/26 US$5.500 -1.96% 333,491
21/08/26 US$5.610 +0.18% 140,353
20/08/26 US$5.600 -1.41% 207,308
19/08/26 US$5.680 +1.43% 212,615
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
5.540USD
Average target price
12.67USD
Spread / Average Target
+128.64%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INGN Stock